Literature DB >> 2271774

Phenotypic analysis of a large number of normal human bone marrow sample by flow cytometry.

C Andreoni1, D Rigal, M Bonnard, J Bernaud.   

Abstract

Bone marrow aspirates from 48 healthy donors (34 adults, 14 children) were analyzed by flow cytometry (FACS Analyzer) after purification of low-density bone marrow cells (Ld BMC) on a density gradient (d = 1,077) and labelling with 23 anti-hematopoietic cell monoclonal antibodies. Based on physical properties, these Ld BMC could be divided into four different populations called E, My, Mo and L, which comprised 14% +/- 9%, 31% +/- 16%, 10% +/- 5% and 45% +/- 14% of these cells, respectively. The phenotypic analysis of these different populations enabled the identification in E, of erythrocytes (Glycophorin A+, Rhesus D+, but negative for early erythroid differentiation markers such as the transferrin receptor (Tf. R) and the FA6-152 antigen); in My of cells of the myeloid lineage (VIM2+, HLA DR-); in Mo of cells of the monocytic lineage (VIM2+, CD14+) plus some myeloblasts (VIM2+, CD14-, HLADR+) and finally in L of a heterogeneous population including: 1. T lymphocytes labelled to the same extent by CD2, CD3, CD5 and CD6 (28% +/- 10%), B lymphocytes assessed by CD19 and CD20 (12% +/- 8%), Pre-B cells (CD10+ = 8% +/- 7%), less than 5% of "natural killer" cells (CD16+ or Leu7+) and finally, less than 6% of myelomonocytes (CD14+ and/or VIM2+). 2. The erythroid lineage (rhesus D+ = 42% +/- 20%, Tf.R+ and FA6-152+ = 32% +/- 12%). 3. Undifferentiated cells or progenitor cells (CD34+ = 7% +/- 5%). 4. Cells unlabelled by any antibodies (approximately 6%). We observed no difference between bone marrow samples from adults or children, with respect to physical properties, and with all but four immunological markers. A significantly higher proportion of B cells (CD19+ and CD10+) (P less than 0.001) and undifferentiated cells (CD34+ and HLADR+) (P less than 0.02) was observed in children. These data, obtained from a large number of bone marrow samples, could be used to quantify the imbalance of some bone marrow disorders.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2271774     DOI: 10.1007/bf01732876

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  22 in total

1.  Antigenic analysis of hematopoiesis. VI. Flow cytometric characterization of My-10-positive progenitor cells in normal human bone marrow.

Authors:  C I Civin; M L Banquerigo; L C Strauss; M R Loken
Journal:  Exp Hematol       Date:  1987-01       Impact factor: 3.084

2.  Fractionation of human bone-marrow mononuclear cells with peanut agglutinin: phenotypic characterization with monoclonal antibodies.

Authors:  Y Gothelf; N Sharon; E Gazit
Journal:  Hum Immunol       Date:  1986-09       Impact factor: 2.850

3.  Isolation of human haematopoietic progenitor cells using monoclonal antibodies.

Authors:  P C Beverley; D Linch; D Delia
Journal:  Nature       Date:  1980-09-25       Impact factor: 49.962

4.  Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development.

Authors:  M R Loken; V O Shah; K L Dattilio; C I Civin
Journal:  Blood       Date:  1987-11       Impact factor: 22.113

5.  A human leukocyte antigen identified by a monoclonal antibody.

Authors:  A E Berger; J E Davis; P Cresswell
Journal:  Hum Immunol       Date:  1981-11       Impact factor: 2.850

6.  B lymphocyte precursors in human bone marrow: an analysis of normal individuals and patients with antibody-deficiency states.

Authors:  E R Pearl; L B Vogler; A J Okos; W M Crist; A R Lawton; M D Cooper
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

7.  Ontogenic studies of lymphoid progenitor cells in human bone marrow.

Authors:  C J Brashem; J H Kersey; F J Bollum; T W LeBien
Journal:  Exp Hematol       Date:  1982-11       Impact factor: 3.084

8.  A monoclonal antibody that detects expression of transferrin receptor in human erythroid precursor cells.

Authors:  D Lebman; M Trucco; L Bottero; B Lange; S Pessano; G Rovera
Journal:  Blood       Date:  1982-03       Impact factor: 22.113

9.  Human leukocyte function-associated antigens on lympho-hemopoietic precursor cells.

Authors:  D Campana; B Sheridan; N Tidman; A V Hoffbrand; G Janossy
Journal:  Eur J Immunol       Date:  1986-05       Impact factor: 5.532

10.  A monoclonal antibody against an erythrocyte ontogenic antigen identifies fetal and adult erythroid progenitors.

Authors:  P Edelman; G Vinci; J L Villeval; W Vainchenker; A Henri; R Miglierina; P Rouger; J Reviron; J Breton-Gorius; C Sureau
Journal:  Blood       Date:  1986-01       Impact factor: 22.113

View more
  5 in total

1.  Multiparametric immunophenotyping of B cells in peripheral blood of healthy adults by flow cytometry.

Authors:  H G Höffkes; G Schmidtke; M Uppenkamp; U Schmücker
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

2.  Single-cell analysis of bone marrow-derived CD34+ cells from children with sickle cell disease and thalassemia.

Authors:  Peng Hua; Noemi Roy; Josu de la Fuente; Guanlin Wang; Supat Thongjuea; Kevin Clark; Anindita Roy; Bethan Psaila; Neil Ashley; Yvonne Harrington; Claus Nerlov; Suzanne M Watt; Irene Roberts; James O J Davies
Journal:  Blood       Date:  2019-12-05       Impact factor: 22.113

3.  Human lymphoid development in the absence of common γ-chain receptor signaling.

Authors:  Lisa A Kohn; Christopher S Seet; Jessica Scholes; Felicia Codrea; Rebecca Chan; Sania Zaidi-Merchant; Yuhua Zhu; Satiro De Oliveira; Neena Kapoor; Ami Shah; Hisham Abdel-Azim; Donald B Kohn; Gay M Crooks
Journal:  J Immunol       Date:  2014-04-25       Impact factor: 5.422

4.  Immunophenotyping of B lymphocytes by multiparametric flow cytometry in bone marrow aspirates of healthy adults.

Authors:  H G Höffkes; G Schmidtke; U Schmücker; M Uppenkamp; G Brittinger
Journal:  Ann Hematol       Date:  1995-09       Impact factor: 3.673

5.  Adhesion molecules on CD34+ hematopoietic cells in normal human bone marrow and leukemia.

Authors:  M A Reuss-Borst; H J Bühring; G Klein; C A Müller
Journal:  Ann Hematol       Date:  1992-10       Impact factor: 3.673

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.